AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

BriaCell Therapeutics Corp.

$3.04 -$4.13 (-57.60%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$3.31
Day Range
$2.95$3.35
Year Range
$2.60$13.09
Market Cap
26.55M
AVG Volume
231.82K
Trailing/Forward PE
-0.33/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
NASDAQUS
Net Income (USD) · A
-60M-40M-20M02017201820192020202120222023202420252026
BCTX Net Income (USD) by year
PeriodNet Income (USD)
2026-38.27M
2025-36.87M
2024-6.27M
2023-27.28M
2022-52.92M
2021-1.11M
2020-3.8M
2019-4.49M
2018-4.19M
2017-2.6M
Operating Income (USD) · A
-60M-40M-20M02017201820192020202120222023202420252026
BCTX Operating Income (USD) by year
PeriodOperating Income (USD)
2026-39.48M
2025-38.17M
2024-45.52M
2023-31.36M
2022-18.17M
2021-6.97M
2020-3.72M
2019-4.83M
2018-3.85M
2017-2.6M
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: BCTX

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one.

BriaCell Therapeutics Corp.
BCTX
Stockpicker

Video analysis: BCTX

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: BCTX

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.